About 6.75 million shares traded or 60.85% up from the average.
Now a second facility, in Vaughan, north of Toronto, has also been found in violation of regulations. As of December 2018, 311 employees were working at the Vaughan facility, more than at its greenhouse in Pelham.
Although the Company, under the supervision of the Special Committee, is preparing a remediation plan for submission to and consideration by Health Canada, Health Canada has advised the Company that it is now unable to provide any guidance about the timing or content of its decisions concerning the Company.
CannTrust Holdings Inc. shares plummeted almost 25 per cent on Monday morning, after the troubled cannabis grower acknowledged that it has received a second non-compliant order from federal regulators, this time relating to its manufacturing facility in Vaughan, Ont.
After a Health Canada inspection of the Pelham facility in mid-November, 2018 Graham Lee, CannTrust's director of quality and compliance, wrote an email to other CannTrust officials, including Mr. Aceto and Mr. Paul, outlining problems at both the Pelham and Vaughan facilities.
Canntrust said that Health Canada has not provided it with any guidance around "the timing or content of its decisions concerning the Company".Читайте также: Jack Black & Jack White Record Jack Gray Collaboration
Markets Insider is looking for a panel of millennial investors.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
Back in July, Health Canada representatives seized thousands of kilograms worth of product they believe was grown in rooms at the Pelham greenhouse that did not yet have government approval. That prompted sharp selling in CannTrust's stock that saw plummet 50% in a matter of weeks.
The company's interim CEO Robert Marcovitch said, "We are continuing to work hard to regain the trust of Health Canada, our patients, shareholders, and partners".
CannTrust added that KPMG was not aware of the information recently shared by the company when the auditor issued its reports, and that it had relied upon representations made by individuals no longer at the company. (NYSE:CTST) news were published by: Globenewswire.com which released: "Barbuto & Johansson, PA Informs Investors of the Pending Class Action Lawsuit Against CannTrust Holdings (NYSE:CTST); Company Suspends Sales and Shipments of All Cannabis Products - GlobeNewswire" on July 15, 2019, also Seekingalpha.com with their article: "ViewRay and AxoGen among healthcare gainers; Nektar Therapeutics among the losers - Seeking Alpha" published on August 12, 2019, Finance.Yahoo.com published: "Analyst Suggests CannTrustâ€™s (NYSE: CTST) Debacle Could Get a Lot Worse: Barbuto & Johansson P.A. Updates Investors of the Pending Class Action Lawsuit Against CannTrust Holdings Inc". We have retained independent consultants who have already started addressing some of the deficiencies noted in Health Canada's report.
Shares of the company were down 34% year-to-date through Friday.При любом использовании материалов сайта и дочерних проектов, гиперссылка на обязательна.
«» 2007 - 2021 Copyright.
Автоматизированное извлечение информации сайта запрещено.
Код для вставки в блог